Q3 2022 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Alembic Pharmaceuticals ltd. Q3 FY '22 Financial Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to Mr. RJ Baheti, Director Finance and CFO; Alembic Pharmaceuticals Ltd. Thank you, and over to you, sir.
Thank you. Good afternoon, friends. Thank you for joining the third quarter results conference call. I'm sure most of you would have received our results by now. However, let me take you through the numbers for the quarter and 9 months ended 31st December 2021.
During the quarter, our total revenue down by 3% to INR 1,272 crores. EBITDA was INR 269 crores, which is 21% of sales. Profit before tax and profit after tax is INR 209 crores and INR 176 crores, respectively. EPS for the quarter is INR 8.9 per share versus INR 14.88 per share in the corresponding quarter in the previous year. As I explained in the previous quarter's call, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
